Nkarta, Inc. - Common Stock — Cash Flow (NASDAQ:NKTX) | MetaTrader

Open full chart Full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -43.51 M-67.93 M-57 M-86.16 M-99.7 M-88.7 M -87.29 M Cash from investing activities -210.08 M32.53 M-184.69 M79.02 M-129.56 M100.32 M 61.9 M Cash from financing activities 329.82 M1.2 M219.01 M691 K226.08 M141 K 147 K Free cash flow -43.51 M-67.93 M-57 M-86.16 M-99.7 M-89.91 M -88.39 M

News

NKTX Stock Up on Upbeat Regulatory Update on Lead Autoimmune Program

Nkarta CEO Hastings sells $53,915 in NKTX stock

Nkarta (NKTX) president Nadir sells $11,693 in shares

Nkarta: Pushing Deeper Into A Discount Vs. Their Holdings, For No Real Reason (NKTX)

Stifel lowers Nkarta stock price target to $11 from $12, keeps Buy rating

Nkarta to present data on B-cell depleting therapy at rheumatology meeting

Nkarta (NKTX): Holding Its Support Steady Ahead Of First Data Readouts In 2025

Nkarta Appoints Shawn Rose Chief Medical Officer & Head of R&D as Company Resets Senior Leadership Role for Autoimmune Focus

Nkarta Downgraded, Analyst Cites Competitive Pressure In Autoimmune Space - Nkarta (NASDAQ:NKTX)

This Alcoa Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - Alcoa (NYSE:AA), Americold Realty Trust (NYSE:COLD)

Nkarta stock rating downgraded at William Blair to Market Perform

Nkarta Reports First Quarter 2025 Financial Results and Corporate Highlights